RecruitingPhase 2NCT04617756
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
Studying Upper tract urothelial carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Intervention
- Patients receiving neoadjuvant therapy before radical nephrectomy(drug)
- Enrollment
- 50 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (9)
- Hôpital Bichat-Claude Bernard, Paris, Paris Cx 20, France
- Institut Paoli Calmette, Marseille, France
- Hôpital Saint Louis, Paris, France
- Hôpital Pitié Salpétrière, Paris, France
- Hôpital Européen Georges Pompidou, Paris, France
- Centre hospitalier Lyon Sud, Pierre-Bénite, France
- Centre Eugène Marquis, Rennes, France
- Hôpital Foch, Suresnes, France
- Iuct Oncopole, Toulouse, France
Collaborators
Pitié-Salpêtrière Hospital · Bichat Hospital · Hopital Foch 92151 Suresnes · Institut Paoli-Calmettes · European Georges Pompidou Hospital · Saint-Louis Hospital, Paris, France · Centre Hospitalier Lyon Sud · Center Eugene Marquis · IUCT ONCOPOLE
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04617756 on ClinicalTrials.govOther trials for Upper tract urothelial carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07321210Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC): A Randomized Clinical TrialTianjin Medical University Second Hospital
- RECRUITINGNCT07452432Korean Prospective Upper Tract Urothelial Carcinoma CohortSamsung Medical Center
- RECRUITINGPHASE2NCT07265947Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaTyra Biosciences, Inc
- RECRUITINGPHASE2NCT07225374Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUCSamsung Medical Center
- ACTIVE NOT RECRUITINGPHASE2NCT07492225Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized TrialChanghai Hospital
- RECRUITINGPHASE2NCT06356155Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial CancerUniversity of Michigan Rogel Cancer Center
- RECRUITINGPHASE2NCT07126119Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUCTianjin Medical University Second Hospital
- RECRUITINGPHASE1NCT06848868Ambulatory Flexible URS for UTUC SurveillanceChinese University of Hong Kong